drugset / Trial / NCT01620476
Safety and Tolerability of Liraglutide in Healthy Japanese Volunteers
RandomizedParallel-groupDouble-blindTreatment
Summary
This trial is conducted in Japan. The aim of this trial is to assess the safety and tolerability of liraglutide in healthy Japanese male subjects.
Timeline
- Start
- 2003-09
- Primary completion
- 2004-03
- Completion
- 2004-03
Publications
- Results Kageyama S, Hirao K, Shimizu A, Matsumura Y, Zdravkovic M, Rasmussen MF, Irie S. Tolerability, pharmacokinetics, and pharmacodynamics of liraglutide, long-acting human GLP-1 analogue - Phase 1 studies in Japanese healthy subjects with type 2 diabetes. Endocrinology and Diabetology 2007; 24 (6): 95-104
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Liraglutide | Peptide | 5 ug/kg | Subcutaneous |
| Subject | Liraglutide | Peptide | 10 ug/kg | Subcutaneous |
| Subject | Liraglutide | Peptide | 15 ug/kg | Subcutaneous |